November 27, 2021

Inflamma

Microalgae to be developed for nutraceutical applications

Yemoja joins MIGAL Institute to pioneer major study of microalgae for Inflammatory Bowel Disease Microalgae cultivation start-up Yemoja, Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation andInflammatory Bowel Disease (IBD). Select beneficial algae will be developed into